AnaptysBio Statistics
NASDAQ: ANABHealth CareBiotechnology: Pharmaceutical PreparationsUSD
46.63-0.77 (-1.62%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
AnaptysBio by the numbers
AnaptysBio has a market capitalization of $1.39 billion based on 29.73M shares outstanding. Its trailing P/E ratio is 7.2, and its forward P/E is 8.7. The stock trades 4.6% below its 50-day average and 9.5% below its 200-day average.
Average daily trading volume is 496.92K shares, or about $23.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ANAB valuation vs. peer median
| Metric | ANAB | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.39B | $1.41B | -2% |
| Avg. volume | 496.92K | 965.94K | -49% |
Peer median across 8 companies: NRIX, ADRX, TYRA, SRPT, KLRA, DMRA, RAPP, QURE.
Valuation
- Market cap
- $1.39B
- P/E (TTM)
- 7.15
- Forward P/E
- 8.66
- Price / sales (latest FY)
- 5.91
- EPS (TTM)
- $6.52
- Shares outstanding
- 29.73M
Price and trading
- Previous close
- 47.40
- Open
- 46.63
- Day range
- 46.05 – 47.66
- 52-week range
- 26.01 – 72.36
- 52-week change
- +76.58%
- Beta
- —
- Volume
- 432.44K
- Average volume
- 496.92K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Sep 21, 2026
Additional statistics
- Market Cap
- 1.39B
- Pe
- 7.15
- Forward Pe
- 8.66
- Eps
- 6.52
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 72.36
- Week52 Low
- 26.01
- Avg Volume
- 496.92K
- Shares Outstanding
- 29.73M
- Ma50
- 48.88
- Ma200
- 51.54
- Earnings Date
- Sep 21, 2026
- Pct From52w High
- -35.56%
- Pct From52w Low
- 79.25%